Nuo Therapeutics, Inc. announced the appointment of Paul D. Mintz, MD, Senior Vice President and Chief Medical Officer of Verax Biomedical, to its board of directors, effective April 7, 2017. The company also announced Joseph Del Guercio is leaving the board due to his expanded responsibilities as President and CEO of the Clark Charitable Foundation, and will serve as an informal board advisor. With these changes, the size of the Nuo board remains at five directors. Prior to joining Verax Biomedical in early 2016, Dr. Mintz served as Director, Division of Hematology Clinical Review, Office of Blood Research and Review, Center for Biologics Evaluation and Research of the U.S. Food and Drug Administration.